Literature DB >> 18261173

Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient.

A Vanacker1, G Fabré, J Van Dorpe, W E Peetermans, B Maes.   

Abstract

A 69-year-old man, with a history of end-stage renal disease due to polyarteritis nodosa, followed by invasive pulmonary aspergillosis secondary to cyclophosphamide and corticosteroids, received a renal transplant 2 years ago under prophylactic treatment with voriconazole. Because of the severity of the aspergillosis, it was decided to continue voriconazole for a prolonged period. Eighteen months after transplantation, the patient developed a severe facial phototoxic reaction. A few months later, he developed multiple actinic keratoses and a large, rapidly expanding, poorly differentiated squamous cell carcinoma (SCC) with perineural invasion and metastatic lymph nodes, necessitating radical surgery and radiotherapy. Voriconazole therapy has been suggested to be involved in the development of multi-focal invasive SCC when complicated by a phototoxic reaction. Therefore, an alternative antifungal prophylaxis regimen (for instance with posaconazole) should be considered when evaluating patients for solid organ transplantation who are at high risk for the development of cutaneous malignancies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18261173     DOI: 10.1111/j.1600-6143.2007.02140.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  11 in total

1.  Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole.

Authors:  Sherrif F Ibrahim; Jonathan P Singer; Sarah T Arron
Journal:  Dermatol Surg       Date:  2010-11       Impact factor: 3.398

2.  Long-term voriconazole and skin cancer: is there cause for concern?

Authors:  Cornelius J Clancy; M Hong Nguyen
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

3.  Voriconazole enhances UV-induced DNA damage by inhibiting catalase and promoting oxidative stress.

Authors:  Vivian Lee; Michael D Gober; Hasan Bashir; Conor O'Day; Ian A Blair; Clementina Mesaros; Liwei Weng; Andrew Huang; Aaron Chen; Rachel Tang; Vince Anagnos; JiLon Li; Sophie Roling; Emilija Sagaityte; Andrew Wang; Chenyan Lin; Christopher Yeh; Cem Atillasoy; Christine Marshall; Tzvete Dentchev; Todd Ridky; John T Seykora
Journal:  Exp Dermatol       Date:  2019-10-29       Impact factor: 3.960

4.  High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients.

Authors:  Jonathan P Singer; Andreas Boker; Christopher Metchnikoff; Maxwell Binstock; Rebecca Boettger; Jeffrey A Golden; David V Glidden; Sarah T Arron
Journal:  J Heart Lung Transplant       Date:  2012-04-06       Impact factor: 10.247

5.  Voriconazole N-oxide and its ultraviolet B photoproduct sensitize keratinocytes to ultraviolet A.

Authors:  K Ona; D H Oh
Journal:  Br J Dermatol       Date:  2015-07-20       Impact factor: 9.302

Review 6.  Voriconazole-associated cutaneous malignancy: a literature review on photocarcinogenesis in organ transplant recipients.

Authors:  Kiyanna Williams; Matthew Mansh; Peter Chin-Hong; Jonathan Singer; Sarah Tuttleton Arron
Journal:  Clin Infect Dis       Date:  2013-12-20       Impact factor: 9.079

7.  Myeloid dendritic cells from human cutaneous squamous cell carcinoma are poor stimulators of T-cell proliferation.

Authors:  Mark J Bluth; Lisa C Zaba; Dariush Moussai; Mayte Suárez-Fariñas; Helen Kaporis; Linda Fan; Katherine C Pierson; Traci R White; Alexander Pitts-Kiefer; Judilyn Fuentes-Duculan; Emma Guttman-Yassky; James G Krueger; Michelle A Lowes; John A Carucci
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

8.  Voriconazole and its clinical potential in the prophylaxis of systemic fungal infection in patients with hematologic malignancies: a perspective review.

Authors:  Amaya Zabalza; Ana Gorosquieta; Encarnación Pérez Equiza; Eduardo Olavarria
Journal:  Ther Adv Hematol       Date:  2013-06

9.  Multifocal aggressive squamous cell carcinomas induced by prolonged voriconazole therapy: a case report.

Authors:  C Morice; A Acher; N Soufir; M Michel; F Comoz; D Leroy; L Verneuil
Journal:  Case Rep Med       Date:  2010-12-16

10.  Update on the optimal use of voriconazole for invasive fungal infections.

Authors:  Asma Lat; George R Thompson
Journal:  Infect Drug Resist       Date:  2011-02-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.